Literature DB >> 7641419

Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13.

H Fujii1, M Nakajima, I Saiki, J Yoneda, I Azuma, T Tsuruo.   

Abstract

Aminopeptidase N/CD13 is a Zn(2+)-dependent exoprotease present on the cell surface as a transmembrane protein. Our previous studies using aminopeptidase inhibitors and antibodies demonstrated that aminopeptidase N is involved in the degradation and invasion of the extracellular matrix (ECM) by metastatic tumor cells. In the present study we transfected human A375M melanoma cells with eukaryotic plasmid expression vectors that contained full length cDNA of aminopeptidase N/CD13 and examined their characteristics. The transfectants that expressed extremely high levels of aminopeptidase N/CD13 degraded type IV collagen and invaded ECM more actively than the parental and control vector-transfected cells. Furthermore, the aminopeptidase N/CD13-transfected A375M cells had significantly augmented lung colonizing potential in nude mice. The results show that the aminopeptidase N/CD13 plays an active role in degradation and invasion of ECM and may be involved in the molecular mechanisms of blood-borne metastasis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641419      PMCID: PMC7088232          DOI: 10.1007/bf00121910

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  20 in total

1.  Immunomodulatory and therapeutic properties of bestatin in mice.

Authors:  J E Talmadge; B F Lenz; R Pennington; C Long; H Phillips; M Schneider; H Tribble
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

2.  Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials.

Authors:  M Nakajima; D R Welch; P N Belloni; G L Nicolson
Journal:  Cancer Res       Date:  1987-09-15       Impact factor: 12.701

3.  Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells.

Authors:  A Menrad; D Speicher; J Wacker; M Herlyn
Journal:  Cancer Res       Date:  1993-03-15       Impact factor: 12.701

4.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

Authors:  L A Liotta; R H Goldfarb; R Brundage; G P Siegal; V Terranova; S Garbisa
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

5.  Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of cell-adhesive molecules.

Authors:  I Saiki; J Iida; J Murata; R Ogawa; N Nishi; K Sugimura; S Tokura; I Azuma
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

6.  Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor.

Authors:  L A Liotta; S Abe; P G Robey; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

7.  Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.

Authors:  B F Sloane; K V Honn; J G Sadler; W A Turner; J J Kimpson; J D Taylor
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

8.  Inhibition of lymph node metastasis of P388 leukemia by bestatin in mice.

Authors:  T Tsuruo; K Naganuma; H Iida; T Yamori; S Tsukagoshi; Y Sakurai
Journal:  J Antibiot (Tokyo)       Date:  1981-09       Impact factor: 2.649

Review 9.  Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

10.  Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro.

Authors:  I Saiki; J Murata; K Watanabe; H Fujii; F Abe; I Azuma
Journal:  Jpn J Cancer Res       Date:  1989-09
View more
  33 in total

1.  Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo.

Authors:  Gopal Pathuri; Andria F Hedrick; Bryan C Disch; John T Doan; Michael A Ihnat; Vibhudutta Awasthi; Hariprasad Gali
Journal:  Bioconjug Chem       Date:  2011-12-20       Impact factor: 4.774

2.  Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment.

Authors:  Liliana Guzman-Rojas; Roberto Rangel; Ahmad Salameh; Julianna K Edwards; Eleonora Dondossola; Yun-Gon Kim; Alan Saghatelian; Ricardo J Giordano; Mikhail G Kolonin; Fernanda I Staquicini; Erkki Koivunen; Richard L Sidman; Wadih Arap; Renata Pasqualini
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

3.  CD13/APN is activated by angiogenic signals and is essential for capillary tube formation.

Authors:  S V Bhagwat; J Lahdenranta; R Giordano; W Arap; R Pasqualini; L H Shapiro
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

4.  Neutral endopeptidase/CD10 and aminopeptidase N/CD13 gene expression as a prognostic factor in non-small cell lung cancer.

Authors:  T Tokuhara; M Adachi; H Hashida; H Ishida; T Taki; M Higashiyama; K Kodama; S Tachibana; S Sasaki; M Miyake
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-08

5.  Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation.

Authors:  D E Wentworth; K V Holmes
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.

Authors:  R Pasqualini; E Koivunen; R Kain; J Lahdenranta; M Sakamoto; A Stryhn; R A Ashmun; L H Shapiro; W Arap; E Ruoslahti
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

7.  CD13 regulates dendritic cell cross-presentation and T cell responses by inhibiting receptor-mediated antigen uptake.

Authors:  Mallika Ghosh; Beata McAuliffe; Jaganathan Subramani; Sreyashi Basu; Linda H Shapiro
Journal:  J Immunol       Date:  2012-04-27       Impact factor: 5.422

8.  A unified mechanism for aminopeptidase N-based tumor cell motility and tumor-homing therapy.

Authors:  Chang Liu; Yang Yang; Lang Chen; Yi-Lun Lin; Fang Li
Journal:  J Biol Chem       Date:  2014-10-29       Impact factor: 5.157

9.  Exploring ligand dissociation pathways from aminopeptidase N using random acceleration molecular dynamics simulation.

Authors:  Ya Liu; GuoGang Tu; XiaoPing Lai; BinHai Kuang; ShaoHua Li
Journal:  J Mol Model       Date:  2016-09-13       Impact factor: 1.810

10.  Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice.

Authors:  Ahamed Hossain; David Heron; Ian Davenport; Thomas Huckaba; Richard Graves; Tarun Mandal; Syed Muniruzzaman; Shusheng Wang; Partha S Bhattacharjee
Journal:  Exp Eye Res       Date:  2016-06-23       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.